Pharmacokinetic Profile of Fentanyl in the Koala (<i>Phascolarctos cinereus</i>) after Intravenous Administration, and Absorption via a Transdermal Patch

Fentanyl was administered as a single intravenous bolus injection at 5 µg/kg to five koalas and fentanyl plasma concentrations for a minimum of 2 h were quantified by an enzyme-linked immunosorbent assay (ELISA). The median (range) fentanyl elimination half-life and clearance were 0.53 (0.38–0.91) h...

Full description

Bibliographic Details
Main Authors: Fumie Tokonami, Benjamin Kimble, Merran Govendir
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Animals
Subjects:
Online Access:https://www.mdpi.com/2076-2615/11/12/3550
_version_ 1827674457929416704
author Fumie Tokonami
Benjamin Kimble
Merran Govendir
author_facet Fumie Tokonami
Benjamin Kimble
Merran Govendir
author_sort Fumie Tokonami
collection DOAJ
description Fentanyl was administered as a single intravenous bolus injection at 5 µg/kg to five koalas and fentanyl plasma concentrations for a minimum of 2 h were quantified by an enzyme-linked immunosorbent assay (ELISA). The median (range) fentanyl elimination half-life and clearance were 0.53 (0.38–0.91) h, and 10.01 (7.03–11.69) L/kg/h, respectively. Assuming an analgesic therapeutic plasma concentration of 0.23 ng/mL (extrapolated from human studies), an intravenous constant infusion rate was estimated at approximately between 1.7 to 2.7 µg/kg/h (using the clearance 95% confidence intervals). A transdermal fentanyl patch was applied to the antebrachium of an additional two koalas for 72 h. Fentanyl plasma concentrations were determined during the patch application and after patch removal at 80 h. The fentanyl plasma concentration was greater than 0.23 ng/mL after 12 to 16 h. While the patch was applied, the maximum fentanyl concentration was approximately 0.7 ng/mL from 32 to 72 h. Fentanyl plasma concentrations increased to 0.89 ng/mL 1 h after the patch was removed, and then decreased to a mean of 0.47 ng/mL at 80 h. The transdermal fentanyl patch is likely to provide some level of analgesia but should be initially co-administered with another faster acting analgesic for the first 12 h.
first_indexed 2024-03-10T04:39:43Z
format Article
id doaj.art-89d5387fd8b7418797d10755b956d3ad
institution Directory Open Access Journal
issn 2076-2615
language English
last_indexed 2024-03-10T04:39:43Z
publishDate 2021-12-01
publisher MDPI AG
record_format Article
series Animals
spelling doaj.art-89d5387fd8b7418797d10755b956d3ad2023-11-23T03:28:42ZengMDPI AGAnimals2076-26152021-12-011112355010.3390/ani11123550Pharmacokinetic Profile of Fentanyl in the Koala (<i>Phascolarctos cinereus</i>) after Intravenous Administration, and Absorption via a Transdermal PatchFumie Tokonami0Benjamin Kimble1Merran Govendir2Currumbin Wildlife Hospital, Currumbin, Gold Coast 4223, AustraliaSydney School of Veterinary Science, The University of Sydney, Camperdown, Sydney 2006, AustraliaSydney School of Veterinary Science, The University of Sydney, Camperdown, Sydney 2006, AustraliaFentanyl was administered as a single intravenous bolus injection at 5 µg/kg to five koalas and fentanyl plasma concentrations for a minimum of 2 h were quantified by an enzyme-linked immunosorbent assay (ELISA). The median (range) fentanyl elimination half-life and clearance were 0.53 (0.38–0.91) h, and 10.01 (7.03–11.69) L/kg/h, respectively. Assuming an analgesic therapeutic plasma concentration of 0.23 ng/mL (extrapolated from human studies), an intravenous constant infusion rate was estimated at approximately between 1.7 to 2.7 µg/kg/h (using the clearance 95% confidence intervals). A transdermal fentanyl patch was applied to the antebrachium of an additional two koalas for 72 h. Fentanyl plasma concentrations were determined during the patch application and after patch removal at 80 h. The fentanyl plasma concentration was greater than 0.23 ng/mL after 12 to 16 h. While the patch was applied, the maximum fentanyl concentration was approximately 0.7 ng/mL from 32 to 72 h. Fentanyl plasma concentrations increased to 0.89 ng/mL 1 h after the patch was removed, and then decreased to a mean of 0.47 ng/mL at 80 h. The transdermal fentanyl patch is likely to provide some level of analgesia but should be initially co-administered with another faster acting analgesic for the first 12 h.https://www.mdpi.com/2076-2615/11/12/3550fentanylkoala<i>Phascolarctos cinereus</i>transdermal patchanalgesiaopioid
spellingShingle Fumie Tokonami
Benjamin Kimble
Merran Govendir
Pharmacokinetic Profile of Fentanyl in the Koala (<i>Phascolarctos cinereus</i>) after Intravenous Administration, and Absorption via a Transdermal Patch
Animals
fentanyl
koala
<i>Phascolarctos cinereus</i>
transdermal patch
analgesia
opioid
title Pharmacokinetic Profile of Fentanyl in the Koala (<i>Phascolarctos cinereus</i>) after Intravenous Administration, and Absorption via a Transdermal Patch
title_full Pharmacokinetic Profile of Fentanyl in the Koala (<i>Phascolarctos cinereus</i>) after Intravenous Administration, and Absorption via a Transdermal Patch
title_fullStr Pharmacokinetic Profile of Fentanyl in the Koala (<i>Phascolarctos cinereus</i>) after Intravenous Administration, and Absorption via a Transdermal Patch
title_full_unstemmed Pharmacokinetic Profile of Fentanyl in the Koala (<i>Phascolarctos cinereus</i>) after Intravenous Administration, and Absorption via a Transdermal Patch
title_short Pharmacokinetic Profile of Fentanyl in the Koala (<i>Phascolarctos cinereus</i>) after Intravenous Administration, and Absorption via a Transdermal Patch
title_sort pharmacokinetic profile of fentanyl in the koala i phascolarctos cinereus i after intravenous administration and absorption via a transdermal patch
topic fentanyl
koala
<i>Phascolarctos cinereus</i>
transdermal patch
analgesia
opioid
url https://www.mdpi.com/2076-2615/11/12/3550
work_keys_str_mv AT fumietokonami pharmacokineticprofileoffentanylinthekoalaiphascolarctoscinereusiafterintravenousadministrationandabsorptionviaatransdermalpatch
AT benjaminkimble pharmacokineticprofileoffentanylinthekoalaiphascolarctoscinereusiafterintravenousadministrationandabsorptionviaatransdermalpatch
AT merrangovendir pharmacokineticprofileoffentanylinthekoalaiphascolarctoscinereusiafterintravenousadministrationandabsorptionviaatransdermalpatch